chr14-67887196-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_133510.4(RAD51B):​c.748T>G​(p.Ser250Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00156 in 1,606,150 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00084 ( 21 hom. )

Consequence

RAD51B
NM_133510.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.06

Publications

6 publications found
Variant links:
Genes affected
RAD51B (HGNC:9822): (RAD51 paralog B) The protein encoded by this gene is a member of the RAD51 protein family. RAD51 family members are evolutionarily conserved proteins essential for DNA repair by homologous recombination. This protein has been shown to form a stable heterodimer with the family member RAD51C, which further interacts with the other family members, such as RAD51, XRCC2, and XRCC3. Overexpression of this gene was found to cause cell cycle G1 delay and cell apoptosis, which suggested a role of this protein in sensing DNA damage. Rearrangements between this locus and high mobility group AT-hook 2 (HMGA2, GeneID 8091) have been observed in uterine leiomyomata. [provided by RefSeq, Mar 2016]
RAD51B Gene-Disease associations (from GenCC):
  • primary ovarian failure
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065518618).
BP6
Variant 14-67887196-T-G is Benign according to our data. Variant chr14-67887196-T-G is described in ClinVar as Benign. ClinVar VariationId is 1678953.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00838 (1277/152300) while in subpopulation AFR AF = 0.0298 (1239/41574). AF 95% confidence interval is 0.0284. There are 14 homozygotes in GnomAd4. There are 602 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAD51BNM_133510.4 linkc.748T>G p.Ser250Ala missense_variant Exon 7 of 11 ENST00000471583.6 NP_598194.1 O15315-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAD51BENST00000471583.6 linkc.748T>G p.Ser250Ala missense_variant Exon 7 of 11 1 NM_133510.4 ENSP00000418859.1 O15315-2

Frequencies

GnomAD3 genomes
AF:
0.00835
AC:
1270
AN:
152182
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0297
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00623
GnomAD2 exomes
AF:
0.00216
AC:
531
AN:
245786
AF XY:
0.00169
show subpopulations
Gnomad AFR exome
AF:
0.0294
Gnomad AMR exome
AF:
0.00123
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00133
GnomAD4 exome
AF:
0.000841
AC:
1223
AN:
1453850
Hom.:
21
Cov.:
30
AF XY:
0.000780
AC XY:
564
AN XY:
722954
show subpopulations
African (AFR)
AF:
0.0306
AC:
1014
AN:
33134
American (AMR)
AF:
0.00135
AC:
59
AN:
43822
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26002
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39558
South Asian (SAS)
AF:
0.000107
AC:
9
AN:
83872
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53322
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5742
European-Non Finnish (NFE)
AF:
0.0000208
AC:
23
AN:
1108302
Other (OTH)
AF:
0.00186
AC:
112
AN:
60096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
52
104
157
209
261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00838
AC:
1277
AN:
152300
Hom.:
14
Cov.:
32
AF XY:
0.00808
AC XY:
602
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0298
AC:
1239
AN:
41574
American (AMR)
AF:
0.00144
AC:
22
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68032
Other (OTH)
AF:
0.00616
AC:
13
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
59
118
178
237
296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00419
Hom.:
12
Bravo
AF:
0.00925
ESP6500AA
AF:
0.0281
AC:
124
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00266
AC:
323
Asia WGS
AF:
0.00289
AC:
11
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 08, 2024
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RAD51B: BS1, BS2 -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.39
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.017
T;.;T;T;.
Eigen
Benign
0.14
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.70
T;T;T;T;T
MetaRNN
Benign
0.0066
T;T;T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Benign
1.3
.;L;L;.;L
PhyloP100
4.1
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.88
N;N;N;N;N
REVEL
Benign
0.059
Sift
Benign
0.44
T;T;T;T;T
Sift4G
Benign
0.16
T;T;T;T;T
Polyphen
0.21
B;B;B;.;B
Vest4
0.32
MVP
0.69
MPC
0.21
ClinPred
0.021
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.27
gMVP
0.41
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33929366; hg19: chr14-68353913; COSMIC: COSV104699691; API